Results of Operations and Financial Condition
Show detailsHide details
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
Myriad Genetics, Inc.
A molecular diagnostics company, Myriad Genetics makes genetic tests that doctors order to gauge hereditary cancer risk, guide drug choices, and screen for prenatal and mental-health conditions. Founded in Salt Lake City in 1991 by a University of Utah geneticist, it became famous for sequencing and patenting the BRCA1 and BRCA2 breast-cancer genes, launching its first test in 1996. The name "myriad" hints at the countless gene possibilities the company explores, and its early gene patents were struck down by the Supreme Court in 2013.
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 5.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 9.01 Financial Statements and Exhibits